S1:E18: Empower Speaks x FHLIP Conference Live Part 7: Karim Vassanji from Bayer

Summary Karim Vassanji Head of Digital Strategy at Bayer Pharmaceuticals Canada, sits down with our host Fahreen Walimohamed to discuss how AI and digital transformation are disrupting the pharmaceutical industry, emphasizing the importance of collaboration, patient-centered approaches, and lessons learned from the COVID-19 pandemic. Key Topics AI's impact on pharmaceutical operations Lessons learned from COVID-19 pandemic digitization Patient-centered healthcare and AI Collaboration between stakeholders in healthcare Takeaways AI allows pharma to operate more efficiently and increase ROI. COVID-19 accelerated digitization in pharma, shifting from face-to-face to digital engagement. Patients are now more informed, changing the traditional doctor-patient dynamic. Collaboration across policymakers, researchers, and industry is crucial for future healthcare innovation. Chapters 00:00 Introduction to AI in Pharmaceuticals 03:20 Impact of COVID-19 on Pharmaceutical Operations 06:13 Collaboration and Co-Creation in Healthcare 08:06 The Role of Patients in Healthcare Innovation ___________________________________________________________ Follow Karim Vassanji on LinkedIn:   / karimvassanji   ____________________________________________________________ Follow Fahreen Walimohamed on LinkedIn:   / fahreen-walimohamed   Follow Fahreen Walimohamed on Instagram: @fahreenw _____________________________________________________________ Follow Empower Speaks on LinkedIn:   / empowerspeaks   Follow Empower Speaks on Instagram: @empowerspeaks